Anti-plasmid activity of Chlorpromazine in types of antibiotics resistant pathogenic bacteria
Abstract
This study was performed to evaluate the ability of chlorpromazine compound to cure the plasmids and remove the antibiotic resistance character of multidrug resistance Gram-negative pathogenic bacteria.
The curing experiment was done by incubating bacterial strains in nutrient broth with sub MIC concentration of chlorpromazine, and the disc diffusion method was used before and after curing to evaluate antibiotic resistance pattern of bacteria. Synergetic test of chlorpromazine with antibiotics that the studied bacteria showed resistance toward also done.
The results showed the ability of chlorpromazine to remove the plasmids from four bacterial genera out of five genera, where the most plasmid removal cases was with E.cloacae, P.aeruginosa, and P.merabilis, and the loss of antibiotics resistance was observed in the same bacterial genera, but P.merabilis showed the most antibiotics resistance losing by three antibiotics out of nine antibiotics that the bacteria were resistant to them before curing. As for the synergistic effect, the compound showed a synergism with only two antibiotic and with the three aforementioned bacterial genera.
From results of this study we concluded the possibility of removing bacteria resistance to antibiotics by eliminating plasmids through using chlorpromazine, and the possibility of using this compound in synergism with antibiotics, this will open the way to find new strategies to treat many diseases caused by resistant bacteria.
Downloads
References
[2] Boren, K., Crown, A., & Carlson, R. (2020). Multidrug and Pan-Antibiotic Resistance—The Role of Antimicrobial and Synergistic Essential Oils: A Review. Natural Product Communications, 15(10), 1934578X20962595
[3] Garner, E., Chen, C., Xia, K., Bowers, J., Engelthaler, D. M., McLain, J., Edwards, M. A., & Pruden, A. (2018). Metagenomic characterization of antibiotic resistance genes in full-scale reclaimed water distribution systems and corresponding potable systems. Environmental science & technology, 52(11), 6113-6125
[4] Ozdemir, K. (2018). curing the drug resistance plasmid in e. coli o157: h7. Applied Ecology And Environmental Research, 17(6), 14715-14727
[5] Carattoli, A. (2013). Plasmids and the spread of resistance. International Journal of Medical Microbiology, 303(6-7), 298-304
[6] Nagvekar, V., Sawant, S., & Amey, S. (2020). Prevalence of multidrug-resistant Gram-negative bacteria cases at admission in a multispeciality hospital. Journal of global antimicrobial resistance, 22, 457-461.
[7] Seal, B. S., Drider, D., Oakley, B. B., Brüssow, H., Bikard, D., Rich, J. O., Miller, S., Devillard, E., Kwan, J., & Bertin, G. (2018). Microbial-derived products as potential new antimicrobials. Veterinary research, 49(1), 1-12
[8] Vrancianu, C. O.; Popa, L. I.; Bleotu, C.; & Chifiriuc, M. C. (2020). Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance. Frontiers in microbiology, 11, 761.
[9] Patwardhan, R. B., Dhakephalkar, P. K., Chopade, B. A., Dhavale, D. D., & Bhonde, R. R. (2018). Purification and characterization of an active principle, lawsone, responsible for the plasmid curing activity of Plumbago zeylanica root extracts. Frontiers in Microbiology, 9, 2618.
[10] Varga, B., Csonka, Á., Csonka, A., Molnár, J., Amaral, L., & Spengler, G. (2017). Possible Biological and Clinical Applications of Phenothiazines. Anticancer research, 37(11), 5983–5993.
[11] Amaral, L., Viveiros, M., & Molnar, J. (2004). Antimicrobial activity of phenothiazines. In vivo (Athens, Greece), 18(6), 725–731.
[12] National Committee for Clinical Laboratory Standards.. Perfor¬mance Standards for antimicrobial disk Susceptibility test approved standard. Wayne, PA: NCCLs; 2000.
[13] Mohammed S; Mahmoud A; Laith M; Najeeb N.(2020) Synergistic Effect of Some Natural Substances in Combination with Antibiotics on MDR Klebsiella isolates, Medico-legal Update, , Vol.20, No. 3
[14] Wiegand, I., Hilpert, K., & Hancock, R. E. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols, 3(2), 163–175.
[15] Oriomah, C., & Akpe, A. R. (2019). Plasmid curing of antibiotic resistant Escherichia coli isolates from urine and stool samples. Journal of Microbiology and Antimicrobials, 11(1), 1-4.
[16] Prestinaci ,F ; Pezzotti ,p and Pantosti, A (2015). Antimicrobial Resistance : a global multifaceted phenomenon . Patho Glob Health 109: (7): 309-318.
[17] Canton R, Morosini MI(2011). Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev; 35(5): 977-91.
[18] Amaral, L., Martins, A., Molnar, J., Kristiansen, J. E., Martins, M., Viveiros, M., Rodrigues, L., Spengler, G., Couto, I., Ramos, J., Dastidar, S., Fanning, S., McCusker, M., & Pages, J. M. (2010). Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In vivo (Athens, Greece), 24(4), 409–424.
[19] Molnár, J., Földeák, S., Nakamura, M. J., Rausch, H., Domonkos, K., & Szabó, M. (1992). Antiplasmid activity: loss of bacterial resistance to antibiotics. APMIS. Supplementum, 30, 24–31.
[20] Snyder, L., Champness, W., & Champness, W. (1997). Molecular genetics of bacteria (Vol. 19). Washington, DC: Asm Press.
[21] Molnár, J., Mándi, Y., Spengler, G., Haszon, I., Túri, S., Kásler, M., & Amaral, L. (2014). Synergism between antiplasmid promethazine and antibiotics in vitro and in vivo. BIOCHEMISTRY AND PHARMACOLOGY, 3(4), Azonosító-1000139.
[22] Amaral, L., Kristiansen, J. E., Viveiros, M., & Atouguia, J. (2001). Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. Journal of Antimicrobial Chemotherapy, 47(5), 505-511.
[23] Banu, H., & Prasad, K. P. (2017). Role of plasmids in microbiology. J Aquac Res Development, 8(466), 2.
[24] Breijyeh, Z., Jubeh, B., & Karaman, R. (2020). Resistance of Gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules, 25(6), 1340.
Copyright © Author(s) . This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
